Subscribe To
PLXP / Why Is PLx Pharma (PLXP) Stock Down 38% Today?
PLXP News
By InvestorPlace
April 12, 2023
Why Is PLx Pharma (PLXP) Stock Down 32% Today?
PLx Pharma (NASDAQ: PLXP ) stock continues to fall on Wednesday as the company gets closer to being delisted from the Nasdaq Exchange . An update from more_horizontal
By InvestorPlace
April 11, 2023
Why Is PLx Pharma (PLXP) Stock Down 38% Today?
PLx Pharma (NASDAQ: PLXP ) stock is taking a beating on Tuesday and there's a couple of reasons investors will want to know about its fall. First off, more_horizontal
By Seeking Alpha
November 11, 2022
PLx Pharma (PLXP) Q3 2022 Earnings Call Transcript
PLx Pharma Inc. (NASDAQ:PLXP ) Q3 2022 Earnings Conference Call November 11, 2022 8:30 AM ET Company Participants Natasha Giordano - President, Chief more_horizontal
By Zacks Investment Research
May 13, 2022
PLx Pharma, Inc. (PLXP) Reports Q1 Loss, Lags Revenue Estimates
PLx Pharma, Inc. (PLXP) delivered earnings and revenue surprises of 4.35% and 11.36%, respectively, for the quarter ended March 2022. Do the numbers h more_horizontal
By GlobeNewsWire
April 22, 2022
PLx Pharma Inc. to Discuss 2022 First Quarter Financial Results on May 13, 2022 Conference Call and Provide Business Update
SPARTA, N.J., April 22, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug delivery more_horizontal
By Seeking Alpha
March 11, 2022
PLx Pharma Inc. (PLXP) CEO Natasha Giordano on Q4 2021 Results - Earnings Call Transcript
PLx Pharma Inc. (PLXP) CEO Natasha Giordano on Q4 2021 Results - Earnings Call Transcript more_horizontal
By Zacks Investment Research
March 11, 2022
Dipexium Pharmaceuticals, Inc. (PLXP) Reports Q4 Loss, Misses Revenue Estimates
Dipexium Pharmaceuticals, Inc. (PLXP) delivered earnings and revenue surprises of -5.80% and 17.51%, respectively, for the quarter ended December 2021 more_horizontal
By GlobeNewsWire
March 1, 2022
PLx Pharma Inc. to Present at Oppenheimer & Co's 32nd Annual Healthcare Conference on March 15, 2022
SPARTA, N.J., March 01, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug delivery more_horizontal